Response Biomedical Corp. of Vancouver, BC at MEDICA 2017 in Düsseldorf -- COMPAMED Trade Fair

Response Biomedical Corp.

1781 - 75th Avenue W., V6P 6P2 Vancouver, BC
Canada

Telephone +1 604 456-6010
Fax +1 604 456-6066
customersupport@responsebio.com

This company is co-exhibitor of
Canadian German Chamber of Industry and Commerce Inc.

Hall map

MEDICA 2017 hall map (Hall 3): stand H14

Fairground map

MEDICA 2017 fairground map: Hall 3

Our range of products

Our products

Product category: Immuno assay systems

RAMP® Procalcitonin

Rapid Diagnostic Test to Detect Procalcitonin Levels in Blood

  • GLOBAL: More than 30 million cases annually worldwide1
  • URGENT: Early detection and treatment of sepsis has been proven to improve patient outcomes and reduce healthcare costs2,3
  • DEADLY: One-third of ICU patients with sepsis die before leaving the hospital4
  • COSTLY: Sepsis is one of the most expensive conditions to treat, with costs exceeding $20 billion USD annually in the US alone5
  • PROCALCITONIN (PCT): is a biomarker elevated in the blood of patients suffering from sepsis. Physicians use PCT to distinguish bacterial sepsis from other causes of similar symptoms6
When every minute counts, early recognition of sepsis is key. Elevated procalcitonin levels mean increased risk for your patient. RAMP® Procalcitonin provides quantitative results in ~15 minutes directly from a small blood sample. When speed, precision and accuracy are critical, the RAMP® Procalcitonin test provides clinicians the results they need for making informed patient management decisions.

RAMP® PROCALCITONIN TEST KIT
  • 25 RAMP® Procalcitonin test cartridges
  • 25 RAMP® Procalcitonin test tips (pouched with cartridges)
  • 25 RAMP® Procalcitonin sample buffer vials
  • 1 Transfer Device
  • 1 Lot Card
  • 1 Package Insert
*Equipment required, but not provided with the test kit: RAMP® Reader or RAMP® 200
*Optional equipment, not provided with the test kit: Accessories

1. Fleischmann et al. Global burden of sepsis: a systematic review. Critical Care 2015, 19(Suppl 1): P21.
2. Kumar et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical
determinant of survival in human septic shock. Crit Care Med 2006. 34:1589-1596.
3. Shorr et al. Economic implications of an evidence-based sepsis protocol: can we improve outcomes
and lower costs? Crit Care Med 2007. 35(5):1257-1262.
4. Vincent et al: Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations
5. Torio et al. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011. HCUP
6. Uzzan et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or
trauma: a systematic review and meta-analysis. Crit Care Med 2006. 34:1996-2003

More Less

Product category: Immuno assay systems

RAMP® CARDIAC TROPONIN I TEST

A Rapid Diagnostic Test for Determination of Elevated Cardiac Troponin I (cTnI) Levels in Blood
 
The RAMP® Cardiac Troponin I test is an accurate, quantitative and rapid diagnostic test that aids in the diagnosis of acute myocardial infarction (AMI) and is ideally suited for both point of care testing and laboratory use.

RAMP® TROPONIN I TEST HIGHLIGHTS
  • Rapid, accurate, lab quality results within minutes
  • Excellent low-end sensitivity comparable to other lab tests
  • Strong correlation with Dimension RxL and Centaur
  • 24 Hour Technical Support available
RAMP® TROPONIN I TEST PRINCIPLES
  • Quantitative immunochromatographic test
  • Sample Medium: EDTA anti-coagulated whole blood
  • Time to Result: < 20 minutes
  • Fluorescent-dyed particles coated with anti-TnI antibodies bind to TnI (if present in the sample)
  • Single use test cartridge with barcode defines lot specific calibration
  • Proprietary RAMP® buffer enhances performance
  • A calibrated transfer device is provided with every kit

More Less

Product category: Immuno assay systems

RAMP® NT-proBNP TEST

A Congestive Heart Failure (CHF) Test to Determine NT-proBNP Cardiac Marker Levels in Blood
 
The RAMP® NT-proBNP test is an accurate, quantitative and rapid diagnostic test that aids in the diagnosis and assessment of severity in individuals suspected of having congestive heart failure (CHF) and can aid in the risk stratification of patients with heart failure.  The RAMP® NT-proBNP test is ideally suited for point of care testing and laboratory use by healthcare professionals.

RAMP® NT-proBNP TEST HIGHLIGHTS
  • Rapid, accurate, lab quality results within minutes
  • Full range NT-proBNP measurement
  • Broad reportable range enables continuous clinical assessment following initial diagnosis
  • Diagnostic accuracy for this test is comparable on RAMP® Reader and Roche Elecsys¹
  • 24 Hour Technical Support available
¹ Lee-Lewandrowski E. et al. Multi-center Validation of the Response Biomedical Corporation RAMP® NT-proBNP Assay with Comparison to the Roche Diagnostics GmbH Elecsys® proBNP Assay. Clinica Chimica Acta 2007;386(1-2):20-24
RAMP® NT-proBNP TEST PRINCIPLES

More Less

Product category: Immuno assay systems

RAMP® D-DIMER TEST

Rapid Diagnostic Test to Detect Elevated D-dimer Levels in Blood
 
Industry research illustrates that the fibrin degradation product (FDP), D-dimer, in general, is a valuable diagnostic marker used as an aid to the rule-out of Venous Thromboembolism (VTE), including thromboembolic events such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)[1-5].

RAMP® D-DIMER TEST HIGHLIGHTS
  • Rapid, precise, lab quality results within minutes
  • Accurate quantification of D-dimer levels in blood
  • 24 Hour Technical Support available

More Less

Product category: Immuno assay systems

RAMP® CREATINE KINASE MB (CK-MB) TEST

A Rapid Diagnostic Test for Determination of Elevated CK-MB Levels in Blood
 
The RAMP® CK-MB I test is a quantitative, rapid diagnostic test for the determination of elevated creatine kinase MB (CK-MB) levels in human blood.   Healthcare professionals use this rapid CK-MB test as an aid in diagnosis of acute myocardial infarction (AMI) and is ideally suited for both point of care testing and laboratory use.

CK-MB TEST HIGHLIGHTS
  • Rapid, accurate, lab quality results within minutes
  • Use to prioritize patient management for those suspected of acute myocardial infarction (AMI)
  • Can be used as a companion product to Troponin I as part of a multi-marker strategy
  • 24 Hour Technical Support available

More Less

Product category: Immuno assay systems

RAMP® MYOGLOBIN TEST

 AMI Rapid Diagnostic Test to Determine Elevated Myoglobin Levels in Blood
 

Ideal for both point of care testing and laboratory use, healthcare professionals use the RAMP® Myoglobin test to aid in the rapid diagnosis of acute myocardial infarction (AMI).

More Less

Product category: Immuno assay systems

RAMP® FLU A + B TEST

Rapid Differential Diagnosis of Influenza A and B Viral Infections in Symptomatic Patients in ~15 Minutes
 
The RAMP® Flu A + B test is a rapid diagnostic test that allows for the objective identification of infected patients from nasopharyngeal swab, nasal wash/aspirate or nasopharyngeal aspirate and is ideally suited for point of care testing by healthcare professionals.

More Less

Product category: Immuno assay systems

RAMP® RSV TEST

Rapid Diagnosis of Respiratory Syncytial Virus (RSV) Infections in ~15 Minutes
 
The RAMP® RSV test is a rapid diagnostic test that aids in the diagnosis of RSV infections using nasopharyngeal swab, nasal wash or nasopharyngeal aspirate specimens and is ideally suited for point of care testing by healthcare professionals.

RAMP® RSV TEST HIGHLIGHTS
  • Clinically proven to be more sensitive than BinaxNow¹
  • Provides rapid, objective, qualitative positive or negative results in 15 minutes
  • Rapid RSV detection combined with other infection control measures may help healthcare facilities improve patient care and help protect children from this respiratory virus
  • Fast, objective results help the laboratory manage workflow
  • LIS connectivity capability
  • 24 Hour Technical Support available
¹ Clinical Evaluation of the 3M™ Rapid Detection RSV Test; Wilson, D.A. et al.; North Shore Health System Laboratories, Lake Success, NY, CVS Poster Presentation, 25th Clinical Virology Symposium (CVS) (2009)

More Less

About us

Company details

Response Biomedical Corp. develops, manufactures and markets the RAMP® system, a rapid diagnostics platform that delivers lab quality performance for efficient patient management in acute care settings.

RAMP® is a global leader in cardiovascular point of care (POC) testing with a wide range of markers available on the platform including Troponin I, CK-MB, Myoglobin, NT-proBNP and D-dimer. For effective and efficient patient care, RAMP® tests aid in the rapid diagnosis of Acute Myocardial Infarction and Heart Failure. RAMP® is ideally suited for both laboratory use and POC testing; POC has the potential to reduce turn around times, increase operational efficiency and improve patient outcomes.

Manufactured in a world class facility in Vancouver, Canada, RAMP® tests are of the highest quality and can be run on either the portable, battery-operated, single-port RAMP® reader or the high throughput, modular, RAMP® 200 reader which has additional compliance features and enhanced connectivity. In addition to cardiovascular tests, RAMP® is sold worldwide for use in infectious disease testing, biodefense and environmental applications. The RAMP® system requires no calibration or maintenance, is easy to use, cost-effective and has minimal service requirements.

When speed, precision and accuracy is critical, the RAMP® platform provides clinicians the results they need for making informed patient management decisions.

More Less